" class="no-js "lang="en-US"> Exact Sciences - Medtech Alert
Saturday, September 30, 2023

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Exact Sciences | Pharmtech Focus

Exact Sciences

About Exact Sciences

Exact Sciences

For more information, please visit our website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences or find Exact Sciences on Facebook.

Related Story

News

 Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S. | MTA

Exact Sciences Launches OncoExTra™ Cancer Therapy Selection Test in the U.S.

February 7 2023

Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced the launch […]

Diseases

 Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients | PTF

Exact Sciences Presents First Time Data Detailing Ability to Predict Radiation Therapy Benefit in Breast Cancer Patients

December 12 2022

Exact Sciences, a leading provider of cancer screening and diagnostic tests, today shared initial clinical […]

Diseases

 Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients | Pharmtech Focus

Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Cancer Testing for More Patients

January 10 2022

Exact Sciences Corp. (NASDAQ: EXAS) announced today it has acquired PreventionGenetics, a genetic testing laboratory, to […]

Diseases

 Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Detection | Pharmtech Focus

Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Detection

November 18 2021

Exact Sciences Corp. (NASDAQ: EXAS) today announced an agreement with Jefferson Health (Jefferson) to conduct research on […]